Literature DB >> 27619890

Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties.

Ulrich Sonnenborn1.   

Abstract

Among the gram-negative microorganisms with probiotic properties, Escherichia coli strain Nissle 1917 (briefly EcN) is probably the most intensively investigated bacterial strain today. Since nearly 100 years, the EcN strain is used as the active pharmaceutical ingredient in a licensed medicinal product that is distributed in Germany and several other countries. Over the last few decades, novel probiotic activities have been detected, which taken together are specific of this versatile E. coli strain. This review gives a short overview on the discovery and history of the EcN strain. © FEMS 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  E. coli Nissle 1917; Escherichia coli; discovery; history; probiotic

Mesh:

Year:  2016        PMID: 27619890     DOI: 10.1093/femsle/fnw212

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  58 in total

1.  Promising discovery of beneficial Escherichia coli in the human gut.

Authors:  Atchareeya Nakkarach; Hooi Ling Foo; Adelene Ai-Lian Song; Sunee Nitisinprasert; Ulaiwan Withayagiat
Journal:  3 Biotech       Date:  2020-06-09       Impact factor: 2.406

Review 2.  A Toxic Environment: a Growing Understanding of How Microbial Communities Affect Escherichia coli O157:H7 Shiga Toxin Expression.

Authors:  Erin M Nawrocki; Hillary M Mosso; Edward G Dudley
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

Review 3.  Genome Editing of Food-Grade Lactobacilli To Develop Therapeutic Probiotics.

Authors:  Jan-Peter van Pijkeren; Rodolphe Barrangou
Journal:  Microbiol Spectr       Date:  2017-09

4.  Xenosiderophore Utilization Promotes Bacteroides thetaiotaomicron Resilience during Colitis.

Authors:  Wenhan Zhu; Maria G Winter; Luisella Spiga; Elizabeth R Hughes; Rachael Chanin; Aditi Mulgaonkar; Jenelle Pennington; Michelle Maas; Cassie L Behrendt; Jiwoong Kim; Xiankai Sun; Daniel P Beiting; Lora V Hooper; Sebastian E Winter
Journal:  Cell Host Microbe       Date:  2020-02-18       Impact factor: 21.023

5.  CRISPR-based curing and analysis of metabolic burden of cryptic plasmids in Escherichia coli Nissle 1917.

Authors:  Halimatun S Zainuddin; Yanfen Bai; Thomas J Mansell
Journal:  Eng Life Sci       Date:  2019-06-03       Impact factor: 2.678

6.  Cellular Stress Upregulates Indole Signaling Metabolites in Escherichia coli.

Authors:  Chung Sub Kim; Jhe-Hao Li; Brenden Barco; Hyun Bong Park; Alexandra Gatsios; Ashiti Damania; Rurun Wang; Thomas P Wyche; Grazia Piizzi; Nicole K Clay; Jason M Crawford
Journal:  Cell Chem Biol       Date:  2020-04-02       Impact factor: 8.116

Review 7.  The Current Hepatic Encephalopathy Pipeline.

Authors:  Alexander J Ryu; Robert S Rahimi; Michael D Leise
Journal:  J Clin Exp Hepatol       Date:  2020-01-14

8.  Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria.

Authors:  Vincent M Isabella; Binh N Ha; Mary Joan Castillo; David J Lubkowicz; Sarah E Rowe; Yves A Millet; Cami L Anderson; Ning Li; Adam B Fisher; Kip A West; Philippa J Reeder; Munira M Momin; Christopher G Bergeron; Sarah E Guilmain; Paul F Miller; Caroline B Kurtz; Dean Falb
Journal:  Nat Biotechnol       Date:  2018-08-13       Impact factor: 54.908

9.  Escherichia coli Nissle 1917 as adjuvant therapy in patients with chronic bacterial prostatitis: a non-blinded, randomized, controlled trial.

Authors:  Celeste Manfredi; Francesco P Calace; Ferdinando Fusco; Carmelo Quattrone; Dario Giordano; Felice Crocetto; Massimiliano Creta; Marco De Sio; Davide Arcaniolo
Journal:  World J Urol       Date:  2021-07-02       Impact factor: 4.226

Review 10.  Iron Acquisition Systems of Gram-negative Bacterial Pathogens Define TonB-Dependent Pathways to Novel Antibiotics.

Authors:  Phillip E Klebba; Salete M C Newton; David A Six; Ashish Kumar; Taihao Yang; Brittany L Nairn; Colton Munger; Somnath Chakravorty
Journal:  Chem Rev       Date:  2021-03-16       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.